期刊
ARTIFICIAL INTELLIGENCE IN MEDICINE
卷 102, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.artmed.2019.101768
关键词
Fuzzy set; Epistasis; Multifactor dimensionality reduction; Classification
资金
- Ministry of Science and Technology, R.O.C. Taiwan [108-2221-E-992-031-MY3, 108-2221-E-214-019-MY3, 108-2811-E-992-502]
Objective: Epistasis identification is critical for determining susceptibility to human genetic diseases. The rapid development of technology has enabled scalability to make multifactor dimensionality reduction (MDR) measurements an effective calculation tool that achieves superior detection. However, the classification of high-risk (H) or low-risk (L) groups in multidrug resistance operations calls for extensive research. Methods and material: In this study, an improved fuzzy sigmoid (FS) method using the membership degree in MDR (FSMDR) was proposed for solving the limitations of binary classification. The FS method combined with MDR measurements yielded an improved ability to distinguish similar frequencies of potential multifactor genotypes. Results: We compared our results with other MDR-based methods and FSMDR achieved superior detection rates on simulated data sets. The results indicated that the fuzzy classifications can provide insight into the uncertainty of H/L classification in MDR operation. Conclusion: FSMDR successfully detected significant epistasis of coronary artery disease in the Wellcome Trust Case Control Consortium data set.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据